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Abstract
Sarcophine-diol (SD), a structural modifications of sarcophine, has shown chemopreventive effects on 7,12-
dimethylbenz(a)anthracene–initiated and 12-O-tetradecanoylphorbol-13-acetate–promoted skin tumor develop-
ments inmice. Tumorigenesis is associatedwith uncontrolled cell growth and loss of apoptosis. In the present study,
the effects of SD on cell growth and apoptosis in human epidermoid carcinoma A431 cells were determined to
assess whether SD could inhibit cell growth and/or induce apoptosis, thus elucidating possible mechanism of
action. MTT assay was used for cell viability; bromodeoxyuridine incorporation assay was used for cell proliferation;
fluorescence-activated cell sorting analysis of annexin V/propidium iodide staining and TUNEL assay were used
for determining apoptotic cells; Western blot analysis was used for determining the expression of caspase-3 and
colorimetric caspase activity assayswere used for determination of caspase-3, -8, and -9 activity. The results showed
that SD treatment at concentration of 200 to 600 μM resulted in a concentration-dependent decrease in cell viability
and cell proliferation in A431 cells, which largely inhibited cell growth. Sarcophine-diol treatment induced a strong
apoptosis and significantly (P < .05) increased DNA fragmentation in A431 cells. Furthermore, SD treatment sig-
nificantly (P < .05) increased the activity and expression of caspase-3 through activation of upstream caspase-
8 in A431 cells rather than the activation of caspase 9. Sarcophine-diol treatment is relatively much less cytotoxic
in monkey kidney normal CV-1 cells. These results suggest that SD decreases cell growth and induces apoptosis
through caspase-dependent extrinsic pathway in A431 cells, and this may contribute to its overall chemopreventive
effects in mouse skin cancer models.
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Introduction
Cancer is the second most common cause of death in the US ac-
counting for one of every four deaths. Among all the cancers, the inci-
dence of nonmelanoma skin cancer, including basal cell carcinoma
and squamous cell carcinoma are the most common malignant neo-
plasms in humans [1]. It has been estimated that more than 1 million
cases of BCC and squamous cell carcinoma are diagnosed each year
in the US alone [2], which is equivalent to the incidence of malignan-
cies in all other organs combined [3]. Therefore, the development of
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effective chemopreventive or chemotherapeutic agents is useful to ad-
dress the risk of cutaneous malignancies.
Chemoprevention refers to the administration of naturally occurring
and/or synthetic compounds to prevent the initiation and/or promo-
tion and/or progression associated with carcinogenesis. This approach
is promising because chemotherapy and surgery have not been fully
effective against the high incidence of most of the cancers [4].
Recently, there has been a considerable interest in the use of marine
natural products for the chemopreventive activity against skin tumor
development [5–10]. Sarcophytol A, which is a cembranoid isolated
from the Okinawan soft coral Sarcophyton glaucum, was reported for
anticancer activity, particularly for skin cancer [11,12] and was stud-
ied by the National Cancer Institute at a preclinical trial level [6].
However, the major limitation with sarcophytol A is its supply because
it is available only in minute quantities in the soft coral [13].
Sarcophine is one of the most abundant cembranolide also iso-
lated from the Red Sea S. glaucum with yields up to 3% of animal
dry weight [14]. It has been reported that semisynthesis of sarcophine
derivatives such as sarcophine-diol (SD) and sarcophine-triol showed
high chemopreventive effects against skin carcinogenesis [7–10]. In
our previous work, topical application of SD (30 μg/100 μl in acetone
per application), one of the structural modifications of sarcophine, has
showed chemopreventive effects on 7,12-dimethylbenz(a)anthracene
(DMBA)–initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)–
promoted skin tumor development in female CD-1 mice [9]. How-
ever, the mechanism(s) of its efficacy is/are not fully investigated. In
the mechanism(s) of chemopreventive agents, studies focused on
blocking the activation of carcinogens and induction of detoxification
pathway in the 1980s [4,15]. However, studies in recent years are more
focused on the modulation of cell survival pathways such as cell cycle
arrest and induction of apoptosis [16]. Tumorigenesis is associated with
uncontrolled cell replication and loss of apoptotic death of cells [17].
Accordingly, in the present study, the effects of SD on cell proliferation
and apoptosis in human epidermoid carcinoma A431 cells in in vitro
system were determined to assess whether SD could inhibit cell growth
and/or induce cell apoptosis.
Materials and Methods
Materials and Reagents
The soft coral S. glaucum was collected from several locations of
the Red Sea in Egypt. Thiazolyl blue tetrazolium bromide (MTT),N -
2-hydroxyethylpiperazine-N ′-2-ethanesulfonic acid (HEPES), EDTA
disodium salt, sodium chloride, sodium dodecyl sulfate (SDS), Triton,
sucrose, and phenylmethanesulphonylfluoride (PMSF) were pur-
chased from Sigma Chemical Co. (St. Louis, MO). Dulbecco’s modi-
fied Eagle’s medium (DMEM), Roswell Park Memorial Institute
medium (RPMI), fetal bovine serum (FBS), trypsin EDTA and phos-
phate buffered saline (PBS) were from Mediatech, Inc. (Herndon,
VA). Dimethyl sulfoxide (DMSO) was obtained from Fisher Scien-
tific (Fair Lawn, NJ). Cell proliferation ELISA kit, leupeptin, and
pepstatin were from Roche Diagnostics GmbH (Mannheim, Ger-
many). Vybrant Apoptosis Kit 2 and APO-BrdU TUNEL assay kit
were purchased from Molecular Probes (Eugene, OR). Primary anti-
body against caspase-3 was from Cell Signaling Technology (Beverly,
MA). Horseradish peroxidase–conjugated goat antirabbit and anti-
mouse secondary antibodies were purchased from BD Biosciences
(Rockville, MD). ECL Kit was bought from Amersham Biosciences
(Piscataway, NJ). Caspase-3, -8, and -9 colorimetric protease assay kits
were from BioSource (Camarillo, CA). Other reagents were obtained
in their highest purity grade available commercially.
Synthesis of SD
Sarcophine was isolated from the soft coral S. glaucum by multiple
extractions with petroleum ether at room temperature following the
reported procedure [6,12] at the laboratories of Faculty of Pharmacy,
Misr International University, Cairo, Egypt. The dried extract was
evaporated under reduced pressure and chromatographed on silica
gel column using hexane–ethyl acetate (1:2) as eluent. Pure sarcophine
was obtained by crystallization from ethanol. Sarcophine-diol was syn-
thesized according to the following procedure: sarcophine was reduced
to its lactone opened ring analog (50 mg, 0.16 mmol) to which sele-
nium dioxide (35.5 mg, 0.32 mmol) in dry 1,4-dioxane (15 ml) was
added, and the reaction mixture was stirred at room temperature for
4 hours. Water was then added to the reaction mixture, and the prod-
uct was extracted with CH2Cl2. Saturated NaHCO3 solution was
used to wash the CH2Cl2 layer, which was dried over anhydrous
Na2SO4. The solvent was evaporated and the residue was chromato-
graphed on silica gel using hexane-acetone (1:1) as an eluent to obtain
SD (7 mg, 13%) [6].
The structure of SD was fully characterized by spectroscopic meth-
ods as shown in Figure 1 and was identical to the analytical sample
prepared according to previously reported method of synthesis [6,12].
Purity is confirmed by HPLC.
Cell Culture
Human epidermoid carcinoma A431 cell line and monkey kidney
CV-1 cell line were purchased from American Type Culture Collec-
tion (Manassas, VA). A431 cells were grown in DMEM, and CV-1
cells were grown in RPMI, both of which were supplemented with
10% heat-inactivated FBS, 100 U/ml penicillin and 100 μg/ml
streptomycin in a humidified atmosphere containing 5% CO2 and
95% air at 37°C.
SD Solution
Sarcophine-diol was dissolved in DMSO to make 0.3-M stock so-
lution, and the stock solution of SD was diluted in DMEM at dif-
ferent concentrations and was immediately used. In all the assays, the
final concentrations of DMSO in DMEM were 0.333%.
Analysis of Cell Viability
Cell viability was determined byMTTassay as described by Dariusz
et al. [18]. A431 cells were plated at a density of 7500 cells per
well, and CV-1 cells were plated at a density of 5000 cells per well
Figure 1. The structure of SD.
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in a 96-well plate. After 24 hours, cells were treated as either DMEM
with 0.333% DMSO alone as control or various concentrations of
SD (50-600 μM) for 24, 48, and 72 hours. At the end of each treat-
ment, MTT stock solution (5 mg/ml) was diluted to 0.5 mg/ml by
DMEM and immediately used. The medium covering the cells was
aspirated off, and then cells were incubated with 50 μl of 0.5 mg/ml
MTT solution for 4 hours at 37°C. Thereafter, 150 μl of DMSO
was added to each well to dissolve the dye crystal formazan, and the
plate was allowed to stand for 1 hour at 37°C and then mixed with
the microplate shaker for 5 minutes to make sure that all purple crys-
tals were dissolved. Absorbance was measured by SpectraMax M2
microplate reader (Molecular Devices, Sunnyvale, CA) at 570 nm,
with the absorbance at 650 nm to correct for background in the pres-
ence of an appropriate blank (without cells). The blank reading was
subtracted from experimental readings, and cell viability was expressed
as the percentage of the absorbance values of SD-treated groups to un-
treated controls.
Analysis of Cell Proliferation
Cell proliferation was assessed by bromodeoxyuridine (BrdU) incor-
poration using colorimetric ELISA Kit (Roche Diagnostics, GmbH,
Mannheim, Germany). Cells were plated and treated as described
for the MTTassay. At the end of each treatment period, cells were la-
beled with BrdU by incubating for 3 hours at 37°C under 5% CO2 to
allow BrdU to incorporate in place of thymidine into the DNA of pro-
liferating cells. Then, the labeling medium was removed by tapping off
the plate. This was followed by adding FixDenat solution (provided in
the kit) and incubating the plate for 30 minutes at room temperature
according to the protocol provided by manufacturer. Subsequently,
the FixDenat solution was removed by tapping off, and cells were in-
cubated with anti–BrdU-POD solution for approximately 90 minutes
at room temperature. Then, the antibody solution was removed and
wells were rinsed with a washing solution. The substrate solution was
added to each well, and the plate was incubated for 20minutes at room
temperature. Thereafter, 1 M H2SO4 was added to each well to stop
the reaction and mixed thoroughly with the shaker for 1 minute. The
absorbance of the samples was measured using a microplate reader
(Molecular Devices) at 450 nm with the absorbance at 690 nm as ref-
erence. The blank (without cells) was performed in each experimental
setup. The absorbance value of blank was subtracted from other exper-
imental values, and cell proliferation was expressed as the percentage of
the absorbance values of SD-treated groups to untreated controls.
Quantitation of Apoptosis by Annexin V/PI Staining
Vybrant Apoptosis Kit 2 (Molecular Probes) was used to quanti-
tate apoptosis. The kit contains annexin V labeled with a fluorophore
that can identify apoptotic cells by binding phosphatidylserine (PS)
exposed on the cytoplasmic surface of the cell membrane of apoptotic
cells. In addition, the kit includes a red fluorescent propidium iodide
(PI) nucleic acid binding dye that stains dead cells. In brief, 2 ×
105 cells in 2-ml medium were plated to each well of the six-well
plate. After 24 hours, cells were treated with either DMEM with
0.333% DMSO alone as control or with various concentrations of
SD (50, 100, and 400 μM) for 48 hours. At the end of the treat-
ment, adherent and nonadherent cells were harvested and washed
twice with ice-cold PBS and then resuspended cells with annexin-
binding buffer to get a final concentration of 1 × 106 cells/ml. Ap-
proximately 1 × 105 cells in 100-μl buffer were incubated in the dark
with 5 μl of annexin V and 1 μl of the 100 μg/ml PI solution for
15 minutes at room temperature. After incubation, 400 μl of annexin-
binding buffer was added to each sample, and the sample was analyzed
with BD FACScan flow cytometry (BDBiosciences, San Jose, CA) using
CellQuest Software (BD Biosciences), which quantitated the percentage
of apoptotic cells in the cell samples.
Quantitation of DNA Fragmentation by TUNEL Assay
The amount of DNA fragmentation in A431 cells induced by SD
treatment was detected by APO-BrdU TUNEL assay kit (Molecular
Probes) as described by the manufacturer. Briefly, cells were plated
and treated as described for annexin V/PI staining. After collecting
cells by trypsinization and washing cells by ice-cold PBS two times,
cells were fixed by 1% (w/v) paraformaldehyde in PBS followed by
70% (v/v) ethanol. The fixed cells were incubated with BrdU-labeled
nucleotide solution followed by incubation with Alexa Fluor 488
dye–labeled anti-BrdU antibody for staining fragmented DNA in
apoptotic cells. The cells were then analyzed by flow cytometry. Posi-
tive and negative control cells provided in the kit were run with each
assay to ensure the proper performance of the assay.
Determination of Cleaved Caspase-3 Expression by
Western Blot Analysis
Cells (2 × 106) in 20-ml medium were plated to each 75-cm2 flask
before drug treatment. After 24 hours of cell attachment, cells were
treated with either DMEM with 0.333% DMSO alone as control or
with SD (100 and 400 μM) for 48 hours. At the end of the treat-
ment, adherent and nonadherent cells were harvested and washed
twice with ice-cold PBS and lysed with 100 μl of lysis buffer contain-
ing 10 mM HEPES, 1% Triton X, 5 mM EDTA, 350 mM sucrose,
1 μg/ml leupeptin, 1 μg/ml pepstatin, and 1 mM PMSF. Samples
then were then passed through the 25 G needle 30 times and were
kept in −20°C freezer for 30 minutes. Samples were processed again
with 25 G needle 30 times and centrifuged at 10,000g for 5 minutes
to remove nucleus and nonprotein material. Finally, proteins for the
assay were obtained by collecting the supernatant and were used for
the determination of cleaved caspase-3 by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot
analysis as described by Zhang et al. [9].
Protein concentration in the supernatant was determined by BCA
protein assay kit (Pierce, Rockford, IL) with albumin as a standard.
Equal amounts of proteins (60 μg) from control, 100-μM SD, and
400-μM SD were loaded to 12.5% SDS-PAGE, and electrophoresis
was run to separate proteins. The proteins in gels were transferred to
nitrocellulose membranes. Membranes were blocked with 5% nonfat
milk in TBS (10 mM Tris and 100 mMNaCl) for 1 hour and probed
with primary antibodies against cleaved caspase-3 and β-actin followed
by appropriate horseradish peroxidase–conjugated secondary antibody
and ECL detection. Western blots were quantitated by using a UVP
Biochem Gel Documentation system (UVP, Inc., Upland, CA).
Colorimetric Caspase-3, -8, and -9 Activity Assays
Activities of caspase-3, -8, and -9 were measured by using ApoTarget
Kits (BioSource International, Camarillo, CA), which were used to de-
termine the caspase proteolytic activities in lysates of mammalian cells.
The protocol provided by the manufacturer was used. In brief, cells
were plated and treated as described for the determination of cleaved
caspase-3 expression. At the end of the treatment, cells were harvested,
washed twice with ice-cold ,PBS and lysed for 30 minutes on ice in the
lysis buffer provided by the kit. Proteins were collected by centrifuging
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at 10,000g for 1 minute. Protein concentration in the supernatant was
determined byBCAprotein assay kit, and samples were diluted to a con-
centration of 1 mg/ml using lysis buffer. Samples containing 50 μg of
proteins in 50-μl lysis buffer were added to the reaction buffer and
different substrates to test the different caspase activities [DEVD
(Asp-Glu-Val-Asp)-pNA substrate for caspase-3, IETD (Ile-Glu-Thr-
Asp)-pNA substrate for caspase-8 and DEVD (Asp-Glue-Val-Asp)-
pNA substrate for caspase-9]. The samples were incubated overnight
at 37°C. On cleavage of respective colorimetric substrate peptides con-
jugated to p-nitroanilide (pNA) to free pNA by various caspases, absorp-
tion of light by free pNA can be quantitated using a spectrophometer
at 400 nm. Comparison of the absorbance of free pNA from SD-
treated samples with controls allows determination of the fold increase
in caspase-3, -8, and -9 activities, respectively.
Statistical Analysis
Data were analyzed with INSTATsoftware (Graph Pad, San Diego,
CA). Analysis of variance followed by the Tukey test was applied to
compare the statistical difference of different SD treatment groups
with untreated controls. Significance in all the experiment was consid-
ered at P < .05. Values were expressed as mean ± SEM.
Results
SD Reduced Cell Viability of A431 Cells
Our aim was to investigate whether SD treatment could inhibit
the growth of skin cancer cells. Therefore, using human epidermoid
carcinoma A431 cells, the effects of SD on cell viability were assessed
by using MTT assay. Cells were treated with various concentrations
of SD (50-600 μM) for 24, 48, and 72 hours. As shown in Fig-
ure 2A, SD (200-600 μM) treatment for 24, 48, and 72 hours re-
sulted in 10% to 55%, 16% to 76%, and 7% to 90% (P < .05 to
.0001), respectively, decreases in cell viability. Interestingly, SD treatment
for 48 hours at low concentrations (100-200 μM) provided a greater
degree of inhibition of cell viability compared with 72 hours treatment.
However, SD treatment at high concentration (300-600 μM) for
72 hours provided a greater decrease in cell viability of A431 cells than
that of 48 hours treatment.
SD Inhibited Cell Proliferation of A431 Cells
In similar treatments as above, the effects of SD on cell prolifera-
tion in A431 cells were investigated by BrdU incorporation assay.
Sarcophine-diol (300-600 μM) treatment for 24, 48, and 72 hours
resulted in 63% to 98%, 26% to 98%, and 19% to 99% (P < .05 to
.0001) decreases in cell proliferation, respectively. Sarcophine-diol
treatment at 200 μM for 24 hours also significantly (P < .001) in-
hibited cell proliferation as shown in Figure 2B. Overall results sug-
gest that SD treatment (100-300 μM) for 24 hours could lead to a
greater inhibition of cell proliferation in A431 cells compared with
those of 48 and 72 hours of treatment.
Furthermore, the ratio of BrdU incorporation to viable cells for
each treatment was calculated to investigate the role of either inhibi-
tion of cell viability or inhibition of cell proliferation caused by SD
on the decrease of cell growth in A431 cells. As shown in Figure 2C ,
inhibitory effects of SD treatment at an early period (24 hours) and
at higher concentrations (400-600 μM) were mainly due to the in-
hibition of cell proliferation because the ratio of proliferative cells to
viable cells was less than 1, whereas inhibitory effects caused by lower
concentrations of SD (100-300 μM) for higher treatment periods
(48 and 72 hours) were largely due to the decrease in cell viability.
SD Induced a Concentration-Dependent Apoptotic Cell Death
We next assessed whether the apoptotic cell death in A431 cells
was observed in response to the treatment of SD. Both control
and SD-treated cells were stained using Vybrant Apoptosis Kit 2.
The apoptotic cells stained with annexin V labeled with Alexa Fluor
488 (green fluorescence) and necrotic cells stained with PI (red fluo-
rescence) were analyzed by flow cytometry. As shown in Figure 3A, a
significant number of A431 cells shifted from viable state (lower left
quadrant) to apoptotic state (lower right quadrant) and showed higher
staining for annexin V (FL1-H) after treatment with different con-
centrations of SD for 48 hours. Figure 3, B and C , summarized the
percentages of apoptotic cells and necrotic cells in control and SD-
treated cell populations obtained after analysis of data from three in-
dependent experiments using CellQuest Software. Sarcophine-diol
treatment for 48 hours at 50-, 100-, and 400-μM concentrations re-
sulted in 19.1%, 41.2%, and 48.6% of apoptotic cell death com-
pared with 8.8% of apoptotic cells in the DMSO-treated control
A431 cell population. However, as shown in Figure 3C , SD treat-
ment for 48 hours at 50-, 100-, and 400-μM concentrations could
not significantly (P < .05) induce necrotic cell death. These results
suggest that SD treatment (50-400 μM) significantly (P < .05) in-
duced apoptotic cell death but not necrotic cell death in A431 cells
in a concentration-dependent manner.
SD Induced DNA Fragmentation in A431 Cells
Annexin V/PI staining represents an early stage of apoptosis,
whereas DNA fragmentation is the biochemical hallmark of apopto-
sis, an irreversible event that commits the cell to die. Using TUNEL
assay, we therefore sought to determine whether SD treatment could
increase DNA fragmentation, a late event in the apoptotic cascade, in
A431 cells [19]. As shown in Figure 4A, after treating A431 cells with
400-μM SD for 48 hours, the marker (M1) in SD-treated sample
contained more number of cells that were DNA-fragmented as indi-
cated by a higher number of green fluorescent cells in SD-treated
sample compared with control cultures. Figure 4B represented the
mean percentages of cells with DNA fragmentation from three inde-
pendent experiments. Data were analyzed using CellQuest Software.
Sarcophine-diol at 400 μM induced a significant (P < .05) amount of
DNA fragmentation in 11.0% of cells, accounting for three-fold of
DNA fragmentation induction over the DMSO-treated control
A431 cells. However, SD at lower concentrations (50-100 μM)
did not induce a significant amount of DNA fragmentation in
A431 cells. These observations suggest that SD could cause DNA
fragmentation in A431 only at a higher concentration.
Apoptosis Induced by SD Involves Caspase-3 Cleavage
Because caspase-3 cleavage is the key event in the process of apop-
tosis, it is used as a marker of apoptosis induction [20]. Next, the ef-
fects of SD treatment on the expression of cleaved caspase-3 were
examined. As shown in Figure 5, SD treatment at 400 μMfor 48 hours
exhibited an intense band at 17 kDa and a light band at 19 kDa, both
of which were bands for cleaved caspase-3. The caspase-3 bands for
control and 100-μMSD treatment were very faint, andmoreover, only
cleaved caspase-3 at 17 kDa was observed for control and 100-μMSD.
These results suggest that SD treatment at 400 μM induce apoptosis
involving the cleavage of caspase-3.
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Figure 2. Effects of SD on cell viability and cell proliferation in A431 cells. Cells were treated with SD (0-600 μM) for 24, 48, and 72 hours,
respectively. At the end of respective treatment, MTT assay (A) and BrdU incorporation assays (B) were performed as detailed in the
Materials and Methods section. Values of MTT assay (A) are mean ± SE of eight replicates in each treatment, whereas values of BrdU
incorporation assay (B) are mean ± SE of four samples in each treatment. (C) Ratio of proliferating cells to viable cells. *P < .05; †P <
.01; ‡P < .001; §P < .0001 indicate statistical significance in SD-treated groups compared with the control.
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Activation of Caspase-3 by SD Is Caspase-8 Dependent
But Caspase-9 Independent
On the basis of results that SD treatment at 400 μM for 48 hours
could cause a strong expression of cleaved caspase-3 in A431 cells, we
also assessed whether SD could increase the activity of caspase-3. Re-
sults in Figure 6A showed that SD treatment at 400 μM for 48 hours
increased 1.7-fold the induction of the activity of caspase-3 over
DMSO-treated control.
In a classic apoptotic cascade, activation of an executioner caspase
such as caspase-3 is mediated through two pathways: an extrinsic
pathway that is mediated by caspase-8 and an intrinsic pathway that
is regulated by caspase-9 [21]. Because SD could induce the activity of
Figure 3. Effects of SD on apoptosis in A431 cells as judged by annexin V/PI staining. Cells were treated with SD (0-400 μM) for 48 hours,
and then cells were collected by brief trypsinization. (A) Dot plot of annexin V (FL1-H)/PI (FL2-H) staining of A431 cells by flow cytometry.
The lower left quadrant contains viable cells, which exclude PI and are negative for annexin V staining. The lower right quadrant shows
apoptotic cells, which still exclude PI but bind to green fluorescence labeled annexin V through PS exposed on the cell surface of apoptotic
cells. The upper quadrants represent necrotic cells that do not exclude PI and display red fluorescence. Percentages of apoptotic cells (B)
and necrotic cells (C) of each treatment after analysis of the FACS data using CellQuest software. In each case, data represent mean ± SE
of three observations. *P < .05 indicates statistical significance in SD-treated groups compared with the control.
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caspase-3, the activities of caspase-8 and -9 were also investigated as
upstream effectors leading to caspase-3 activation. Figure 6B showed
that SD treatment at 400 μM for 48 hours significantly (P < .05) in-
duced a 1.9-fold increase of the caspase-8 activity over DMSO-treated
control, whereas SD treatment at 400 μM for 48 hours cause com-
parable caspase-9 activity as control (Figure 6C ). However, SD at
lower concentration (50 and 100 μM) could not induce the activity
of caspase-3, -8, and -9 (data not shown). These results indicated
that SD treatment at 400 μM for 48 hours caused the activation of
caspase-3, which was caspase-8 dependent but caspase-9 independent.
SD Did Not Increase Caspase-3 Activity in CV-1 Cells
Next, we wanted to investigate the effects of SD on the normal cell
line. Therefore, using monkey kidney CV-1 cells, the effects of SD
on cell viability and apoptosis were assessed. Results showed that SD
treatment for 72 hours at 800 μM inhibited 44% of cell viability in
CV-1 cells, and SD treatment at 400 μM for 48 hours did not sig-
nificantly induce the activity of caspase-3 (data not presented).
Discussion
In recent years, marine natural products have gained considerable
attention as cancer chemopreventive agents [5–10], such as sarcophy-
tol A, a cembranoid isolated from the Okinawan soft coral Sarcophy-
ton. Sarcophytol A was studied by the National Cancer Institute at a
preclinical trial level for skin cancer [6]. Sarcophine is one of the
most abundant cembranolide isolated from the Red Sea Sarcophyton.
It has been reported that semisynthesis of sarcophine derivatives such
as SD and sarcophine-triol showed high chemopreventive effects
against skin carcinogenesis in mouse models [7–10]. In our pervious
studies, SD showed chemopreventive effects on DMBA-initiated and
TPA-promoted skin tumor developments in female CD-1 mice by
enhancing the expressions of caspase-3 and -8 and decreasing
Figure 4. Effects of SD on DNA fragmentation in A431 cells. Cells were treated with SD (0-400 μM) for 48 hours, and the cells were
collected by brief trypsinization. (A) Histograms show the data obtained by TUNEL assay. The marker (M1) includes the apoptotic cells
with fragmented DNA, which were positive for green fluorescence. (B) Percentages of apoptotic cells with fragmented DNA in the SD-
treated and untreated cell populations. In each case, data represent mean ± SE of three observations. *P < .05 indicates statistical
significance in SD-treated groups compared with the control.
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COX-2 levels [9]. But the detailed mechanism(s) of its efficacy were
not well studied. The present study was designed to elucidate the
mechanism(s) of action of SD because it may result in the design
of novel approaches by which cancer chemopreventive agents could
target. Inhibition of cell growth and induction of apoptosis are two
key events that many chemopreventive agents target [16,22–24]. Ac-
cordingly, in this study, the effects of SD on cell growth and apop-
tosis in skin cancer–derived human epidermoid carcinoma cells were
investigated. The hypothesis that was tested in this study was whether
SD could inhibit cell growth and/or induce apoptosis.
Ourdata demonstrated that SD treatment resulted in a concentration-
dependent loss of cell viability as judged by testing cell’s mitochondrial
metabolic activity usingMTTassay. Sarcophine-diol treatment also in-
hibited A431 cell proliferation as measured by testing the amount of
BrdU incorporated to DNA during DNA synthesis. Both inhibitions
of cell viability and cell proliferation contributed to the overall inhibi-
tion of cell growth by SD treatment in A431 cells.
Apoptosis or programmed cell death is the physiological process by
which unwanted or undesirable cells are eliminated during develop-
ment and other normal biologic process without causing damage to
surrounding tissues. An increasing number of chemopreventive agents
have been shown to stimulate apoptosis in premalignant and ma-
lignant cells in vitro or in vivo [16]. Thus, the present study also in-
vestigated whether SD treatment could induce apoptosis in A431
malignant cancer cells in vitro. During apoptosis, many different cell
changes occur such as loss of phospholipids asymmetry of the plasma
membrane, cell shrinkage, activation of proteases, mitochondrial
changes, and internucleosomal DNA fragmentation [25]. These apop-
totic cell alterations can be detected by different flow cytometric tech-
niques. In an early stage of apoptosis, PS is translocated from the inner
side of the plasma membrane to the outer layer, and thus, PS becomes
exposed at the external surface of the cell. Alexa Fluor 488–labeled an-
nexin V, in the presence of calcium ions, immediately adheres to PS,
which results in green fluorescence of the apoptotic cells [26–28].
However, the translocation of PS to the external surface of the cell
not only is unique to apoptosis but also occurs during cell necrosis,
which is an accidental cell death, a pathologic process occurring when
cells are exposed to a serious physical or chemical insult [27,28]. The
difference between these two forms of cell death is that during the ini-
tial stages of apoptosis, the cell membrane remains intact, whereas ne-
crosis is accompanied by loss of cell membrane integrity and leakage of
cellular constituents into the environment [27]. Therefore, another
red fluorescent PI nucleic acid binding staining is performed in con-
junction with annexin V to distinguish apoptotic and necrotic cells.
Necrotic cells do not exclude PI and show red fluorescence, whereas
apoptotic cells exclude PI with little or no red fluorescence.
In the later stage of apoptosis, the biochemical hallmark is the frag-
mentation of the genomic DNA, an irreversible event that commits
the cell to die [28,29]. DNA fragmentation can be detected by in-
corporating labeled nucleotides such as 5-bromo-2′-deoxyuridine 5′-
triphosphate (BrdUTP) onto the free 3′-OH ends of the fragments
using terminal deoxynucleotidyl transferase (TdT) enzyme followed
by detection of the labeled molecule with fluorescein isothiocyanate–
labeled antibody. This type of assay, often referred to as the TUNEL
Figure 6. Effects of SD on activities of caspase-3, -8, and -9 in A431
cells. Cells were treated with SD (0-400 μM) for 48 hours, and then
enzymatic activity in cell lysates was quantified by measuring chro-
mophores obtained from cleaved substrates. (A) Caspase-3 activity
was assessed as the cleavage of DEVE-pNA to synthetic tetrapep-
tide DEVD and chromophore pNA. (B) Caspase-8 activity was deter-
mined by the cleavage of IETD-pNA to synthetic tetrapeptide IETD
and chromophore pNA. (C) Caspase-9 activity was investigated by
the cleavage of LEHD-pNA to synthetic tetrapeptide LEHD and
chromophore pNA as detailed in the Materials and Methods sec-
tion. Data are shown as the percentage of the absorbance values
to controls and represent mean ± SE of three independent sam-
ples. *P< .05 indicates statistical significance in SD-treated groups
compared with the control.
Figure 5. Effects of SD on expression of cleaved caspase-3 in
A431 cells. Cells were treated with SD (0-400 μM) for 48 hours,
and then cells were collected by brief trypsinization. Total cell ly-
sates were prepared and loaded to SDS-PAGE and Western blot
analysis. Membranes were then probed with cleaved caspase-3
and β-actin antibodies followed by appropriate secondary antibody
and ECL detection.
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(TdT dUTP Nick End Labeling) assay, allows monitoring the per-
centage of DNA-fragmented cells with green fluorescence in the cell
samples [26].
Our data showed that SD treatment (50-400 μM) for 48 hours
could significantly (P < .05) induce apoptotic cell death but not ne-
crotic cell death as judged by annexin V/PI staining. Sarcophine-diol
treatment at 400 μM also caused a significant (P < .05) amount of
DNA fragmentation as judged by TUNEL assay in A431 cells. These
results suggest that SD at low concentrations (50 and 100 μM) could
cause apoptotic cell death by loss of phospholipids asymmetry of the
plasma membrane but not DNA fragmentation in A431 cells. How-
ever, a high concentration of SD (400 μM) could induce apoptosis in
A431 by both loss of the plasma membrane’s phospholipids asymme-
try and DNA fragmentation.
In a classic apoptosis, apoptotic cell death can be initiated by either
death receptor pathway (extrinsic pathway) or mitochondrial path-
way (intrinsic pathways), both of which can activate caspase-3. Acti-
vation of caspase-3 results in the cleavage of the inhibitor of the
caspase-activated deoxyribonuclease, and the caspase-activated deoxy-
ribonuclease becomes active leading to DNA fragmentation and ap-
optotic cell death [30]. For the death receptor pathway, activation of
death receptors using ligands leads to caspase-8 activity. Two routes
have been identified to activate caspase-3 by caspase-8. In one route,
caspase-8 directly processes pro–caspase-3 in the downstream. In an-
other route, caspase-8 cleaves Bid, a member of the Bcl-2 family. The
truncated Bid then translocates to mitochondria and stimulates the
release of cytochrome c, which activates caspase-9 together with
Apaf-1. The activated caspase-9 causes processing of pro–caspase-3
to the activated form. For the mitochondrial pathway, the balance
of proapoptotic and antiapoptotic members of the Bcl-2 family is
thought to regulate the permeability of mitochondria and the release
of cytochrome c from the mitochondria to cytosol. The cytochrome
c then activates caspase-9 together with Apaf-1, and caspase-9 in turn
activates caspase-3 [21,30]. Accordingly, in our study, first the expres-
sion of cleaved caspase-3 and the activity of caspase-3 were investigated
to assess whether SD causes apoptosis through a classic pathway. The
results showed that SD treatment at 400 μM for 48 hours led to a
strong cleaved caspase-3 band compared with untreated control, and
similarly, SD treatment at 400 μM for 48 hours increased 1.7-fold the
induction of the activity of caspase-3 over untreated control. These re-
sults suggest that SD treatment at a higher concentration (400 μM)
induces apoptosis through a caspase-dependent pathway. Further-
more, extrinsic pathway and/or intrinsic pathway triggered by SD
in A431 cells were determined. Results showed that SD treatment at
400 μM for 48 hours significantly (P < .05) induced the activity of
caspase-8 but not caspase-9, indicating that SD induced the activity
of caspase-3 through extrinsic pathway, which was mediated by the
activation of caspase-8. However, SD at lower concentrations (50
and 100 μM) could not induce the cleavage of caspases, although
SD at those concentrations could significantly (P < .05) cause loss
of the plasma membrane’s phospholipids asymmetry in A431 cells.
These observations suggested that SDmight induce apoptosis through
other mechanism(s) at lower concentrations, such as through caspase-
independent pathway [31,32].
Results also showed that SD treatment for 72 hours at 800 μM in-
hibited 44% of cell viability in monkey kidney CV-1 cells compared
with SD treatment at 400 μM that inhibited 62% of cell viability in
A431-1 cells. Moreover, SD treatment at 400 μM for 48 hours in-
creased 1.7-fold the induction of the activity of caspase-3 in A431 cells,
whereas in monkey kidney normal cells, SD treatment at 400 μM for
48 hours did not significantly increase the activity of caspase-3. Those
results suggest that SD exhibits much less cytotoxicity in normal cells
than that in skin tumor cells.
In conclusion, SD inhibits cell growth and induces apoptosis pos-
sibly through a caspase-dependent extrinsic pathway of A431 cells,
which may contribute to the overall chemopreventive effects of SD
observed in mouse skin cancer model [9]. Our previous investigation
indicated that SD is a very potent chemopreventive agent in DMBA-
TPA carcinogenesis protocol in CD-1 mice because it resulted in a
significant decrease in skin tumor development at 30 μg per applica-
tion compared with other chemopreventive agents that resulted in
similar effects at milligram application [33–37]. For example, α-santalol
inhibited DMBA-initiated and TPA-promoted and UVB-induced skin
tumor development in mice at 5 mg per application [33,34]; curcumin
at 1.1 to 3.7 mg per application inhibited DMBA-initiated and TPA-
promoted skin tumor development inmice [35]; and topical application
of (−)-epigallocatechin-3-gallate at 1-mg/cm2 skin area per application
prevented photocarcinogenesis in wild type (C3H/HeN)mice [36] and
silibinin at 9 mg per application prevented UV radiation–caused skin
damages in SKH-1 hairless mice [37]. We anticipated that SD would
be equally potent in in vitro assays as detailed in this study. However,
SD was found to have significant effects on various parameters studied
at relatively higher concentrations compared with other chemopreven-
tive agents such as α-santalol [17], curcumin [38], (−)-epigallocatechin-
3-gallate [39], and silibinin [39]. A possible explanation could be that
SD is metabolized in vivo, and metabolite(s) is/are more potent than
parent SD because chemopreventive agent(s) or SD is not as effective
in human epidermoid carcinoma A431 malignant cancer cells as it is
in preneoplastic cells under in vivo conditions. Further studies on the
effects of metabolite(s) of SD on in vivo animal models and on in vitro
cell culture studies are needed to elucidate the mechanism(s) of action
of SD. Sarcophine-diol has an excellent potential to be a potent chemo-
preventive agent for the nonmelanoma skin cancer development.
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